Edge Therapeutics Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $15.8M

Edge Therapeutics General Information

Description

Edge Therapeutics Inc operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. Its core objective lies in the development and commercialization of therapies for serious unmet medical conditions, especially neurological disorders in the hospital setting. The company is currently evaluating EG-1962, its lead product candidate, in the Phase 3 NEWTON 2 study in adult patients with aneurysmal subarachnoid hemorrhage (aSAH). Edge uses its trademark platform known as Precisa, which enables the creation of polymer-based therapeutics capable of delivering directly to the site of injury, without affecting other areas of the body resulting in side-effects.

Contact Information

Website
www.edgetherapeutics.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 300 Connell Drive
  • Suite 4000
  • Berkeley Heights, NJ 07922
  • United States
Primary Industry
Drug Discovery
Acquirer
PDS Biotechnology
Vertical(s)
TMT, Life Sciences
Corporate Office
  • 300 Connell Drive
  • Suite 4000
  • Berkeley Heights, NJ 07922
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Edge Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
12. Merger/Acquisition 15-Mar-2019 $15.8M Completed Profitable
11. Secondary Transaction - Open Market 06-Mar-2018 Completed Profitable
10. General Corporate Purpose 29-Aug-2016 Completed Profitable
9. IPO 01-Oct-2015 Completed Profitable
8. Later Stage VC (Series C2) 08-Apr-2015 Completed Generating Revenue
7. Later Stage VC (Series C1) 13-Nov-2014 Completed Generating Revenue
6. Mezzanine 08-Sep-2014 Completed Generating Revenue
5. Early Stage VC 18-Mar-2013 Completed Generating Revenue
4. Early Stage VC 13-Sep-2012 $118K $1.67M Completed Startup
3. Accelerator/Incubator 11-Jun-2012 $700K $1.55M Completed Startup
To view Edge Therapeutics’s complete valuation and funding history, request access »

Edge Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Edge Therapeutics Inc operates as a clinical stage biotechnology company, principally involved in drug discovery in the
Drug Discovery
Berkeley Heights, NJ

San Diego, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Edge Therapeutics Competitors (1)

One of Edge Therapeutics’s competitors is Biosplice Therapeutics, a Private Equity-Backed company based in San Diego, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Biosplice Therapeutics Private Equity-Backed San Diego, CA
You’re viewing 1 of 1 competitors. Get the full list »

Edge Therapeutics Former Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds
Alpine Meridian Venture Capital Minority
BioMed Ventures Corporate Venture Capital Minority
Biobrit Venture Capital Minority
Delaware Crossing Investor Group Angel Group Minority
Franklin Templeton Asset Manager Minority
You’re viewing 5 of 14 investors. Get the full list »

Edge Therapeutics Acquisitions (1)

Edge Therapeutics’s most recent deal was a Reverse Merger with PDS Biotechnology. The deal was made on 18-Mar-2019.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
PDS Biotechnology 18-Mar-2019 Reverse Merger Biotechnology
To view Edge Therapeutics’s complete acquisitions history, request access »

Ready to get started?

Request a free trial

Edge Therapeutics FAQs

  • When was Edge Therapeutics founded?

    Edge Therapeutics was founded in 2008.

  • Where is Edge Therapeutics headquartered?

    Edge Therapeutics is headquartered in Berkeley Heights, NJ.

  • What industry is Edge Therapeutics in?

    Edge Therapeutics’s primary industry is Drug Discovery.

  • Is Edge Therapeutics a private or public company?

    Edge Therapeutics is a Private company.

  • What is the current valuation of Edge Therapeutics?

    The current valuation of Edge Therapeutics is .

  • What is Edge Therapeutics’s current revenue?

    The current revenue for Edge Therapeutics is .

  • How much funding has Edge Therapeutics raised over time?

    Edge Therapeutics has raised $185M.

  • Who are Edge Therapeutics’s investors?

    Alpine Meridian, BioMed Ventures, Biobrit, Delaware Crossing Investor Group, and Franklin Templeton are 5 of 14 investors who have invested in Edge Therapeutics.

  • Who are Edge Therapeutics’s competitors?

    Biosplice Therapeutics is a competitor of Edge Therapeutics.

  • When was Edge Therapeutics acquired?

    Edge Therapeutics was acquired on 15-Mar-2019.

  • Who acquired Edge Therapeutics?

    Edge Therapeutics was acquired by PDS Biotechnology.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process